Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 17, 2014

Drug Name	Review Type	Class	Manufacturer
Otezla	New Drug Initial Review	Phosphodiesterase 4 Inhibitor	Celgene
Hemangeol	New Drug Initial Review	Beta-Adrenergic Blocker	Pierre Fabre
Opsumit	New Drug Initial Review	Pulmonary Aterial Hypertension	Actelion
Orenitram ER	New Drug Initial Review	Pulmonary Aterial Hypertension	United Therapeutics
Mycamine	New Drug Initial Review	Anti-fungal	Astellas
Ambisome	New Drug Initial Review	Anti-fungal	Astellas
Brilinta	PDL Appeal	Platelet Aggregation Inhibitor	Astra Zeneca

Footer